The Interdisciplinary Biomedical Graduate Program is an umbrella-style program built around a core of modern cell and molecular biology. After completing laboratory rotations and required first year course work, students match with a research mentor and transfer into one of four participating PhD granting programs. The program offers students choice and opportunities to explore different approaches to research.
The Cell Biology and Molecular Physiology (CBMP) graduate program is made up of a dynamic group of investigators and students who use the modern-day tools of biochemistry, genetics, imaging, and molecular biology to understand the integrated biology and physiology of cells, organs, and whole animals.
The Cellular and Molecular Pathology (CMP) program integrates cellular and molecular biology with the study of human diseases, often in the context of Regenerative Medicine with translational goals. Utilizing the latest technologies, students in the program have opportunities to study both normal and diseased tissues and cells in order to solve basic and applied research problems.
The Molecular Genetics and Developmental Biology (MGDB) program brings together faculty in both basic and applied sciences, including researchers from the School of Medicine, University of Pittsburgh Cancer Institute, Magee-Womens Research Institute, and Biological Sciences. MGDB research is at the cutting edge of many emerging fields, including developmental and reproductive biology, stem cell biology, proteomics, computational biology, and genomics.
Biomedical research in the Molecular Pharmacology program is focused on molecular and cellular mechanisms of intracellular signaling using a combination of biochemical, molecular biological, biophysical, ultrastructural, and imaging approaches. Basic information on cellular communication in health and disease provides the basis for the development and testing of novel therapeutic agents.